QT
SANA icon

Quantbot Technologies’s Sana Biotechnology SANA Stock Holding History

Quantbot Technologies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,287
Closed -$5.24K – 2102
2025
Q4 		$5.24K Buy
+1,287
New +$5.76K ﹤0.01% 1620
2025
Q2 		– Sell
-33
Closed -$55 – 1919
2025
Q1 		$55 Hold
33
– – ﹤0.01% 1415
2024
Q4 		$54 Sell
33
-170
-84% -$507 ﹤0.01% 1423
2024
Q3 		$844 Buy
+203
New +$1.07K ﹤0.01% 1387
2023
Q2 		– Sell
-7,500
Closed -$24.5K – 1907
2023
Q1 		$24.5K Buy
7,500
+5,700
+317% +$22.8K ﹤0.01% 1339
2022
Q4 		$7.11K Sell
1,800
-16,159
-90% -$79K ﹤0.01% 1533
2022
Q3 		$107K Sell
17,959
-12,693
-41% -$91.6K 0.01% 1076
2022
Q2 		$197K Buy
+30,652
New +$195K 0.02% 925

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Quantbot Technologies's SANA Position: Q1 2026 in Review

Quantbot Technologies sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 1,287 shares — an estimated $5.24K sold.

Quantbot Technologies first reported a position in SANA in Q2 2022 and held it in 8 quarters. The position peaked at $197K in Q2 2022. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Quantbot Technologies reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 1,287 Sana Biotechnology shares in Q1 2026, an estimated $5.24K.
  • Quantbot Technologies first reported a position in Sana Biotechnology in Q2 2022 and held it in 8 quarters.
  • Quantbot Technologies's Sana Biotechnology position peaked at $197K in Q2 2022.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.